Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Gala vs NativeMed

Gala and NativeMed both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
Gala logo

Gala

8.7
★★★★☆4.4/5

Best for: moving between compounded and brand without changing seller

Visit Gala →
VS
NativeMed logo

NativeMed

7.0
★★★★☆3.5/5

Best for: compounded semaglutide at $149/month

Visit NativeMed →

If you are choosing between Gala and NativeMed, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Gala leads our six-part score, 8.7 to 7.0. One of the two has an FDA warning letter on record, covered below.

Gala vs NativeMed price

Gala and NativeMed start at the same figure, $149 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.

Drug by drug: Semaglutide is cheaper at NativeMed ($149 a month vs $179 a month); tirzepatide is cheaper at Gala ($149 a month vs $183 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format, Gala prices compounded injections and brand-name pens, while NativeMed prices compounded injections.

If you want the FDA-approved brand rather than a compounded version, Gala is the only one of the two with a brand-name price.

Where each one treats patients

Gala lists 50 states, and NativeMed does not publish where it ships.

Pricing

Gala

Compounded GLP-1 (all doses)Compounded
$179$129/mo
Save 28% right now
semaglutide

$179/mo on a yearly subscription, all doses included. Gala's FAQ says 'starting at just $199 per month (with a 3-month plan).' A promo page offers 'starting at $129/month with $120 off your first shipment' on monthly, 3-, 6- and 12-month plans. Exact plan prices appear only after the intake questionnaire.

Compounded GLP-1/GIP (all doses)Compounded
$179/mo
tirzepatide

$179/month on a yearly subscription, all doses included; the $120-off-first-shipment promo applies. Tirzepatide plan prices are shown only after intake.

Microdosing GLP-1/GIPCompounded
$149/mo
tirzepatide

$149/month, yearly subscription; 'Low-dose GLP-1/GIP for sustained energy, sleep and metabolic balance.'

Ozempic (brand)Brand-name
$1299/mo
semaglutide

'Ozempic® Brand-name semaglutide $1,299/month' — unchanged. Wegovy pill still 'Coming soon / Pricing at launch' (not a priced row).

NativeMed

Compounded semaglutide (sale)Compounded
$149/mo
semaglutide
Compounded tirzepatide (sale)Compounded
$183/mo
tirzepatide

What each price covers

Both prices cover the medication itself and shipping.

Gala's price also covers the clinician visit, which NativeMed does not claim.

Gala is silent on lab work and coaching.

NativeMed is silent on the clinician visit, lab work and coaching.

Gala

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

NativeMed

Covered by the monthly price

Medication

In the price

Clinician visits

Not stated

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, Gala scores 8.7 and NativeMed 7.0 out of 10.

Gala is stronger on value (8.7 vs 7.3), trust & safety (7.5 vs 3.5), accessibility (10.0 vs 5.0) and support (7.0 vs 4.5).

Effectiveness and user experience are within half a point.

How we score

Gala

8.7/10

Overall

NativeMed

7.0/10

Value25%

8.7A
vs
B
7.3

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.5A
vs
B
3.5

Accessibility10%

10.0A
vs
B
5.0

Support10%

7.0A
vs
B
4.5

FDA warning letters

The FDA sent NativeMed a warning letter dated June 8, 2026 (letter 728287), and it is still open.

Gala has no FDA warning letter on record with us.

Features & Coverage

FeatureGalaNativeMed
Starting Price$149/mo$149/mo
Features✓7 features5 features
States Available50Not disclosed
Compounded✓ Yes✓ Yes
Brand Name✓ Yes—
FSA/HSA Accepted——
FDA Warning Letters✓None1 letter

About Gala

A yearly subscription is the format: compounded semaglutide and compounded tirzepatide are sold that way, with a cheaper microdosing program beside them and brand-name Ozempic on the same menu. The corporate name is AI Coaching Inc., which does business as Gala GLP-1 and is incorporated in Delaware. Providers licensed in every one of the 50 states, plus shipping at no cost, are what the marketing site claims. A Wegovy pill taken orally is flagged as coming soon.

Read our full Gala review →

About NativeMed

NativeMed, LLC is a Miami, FL-based cash-pay telehealth seller. Compounded semaglutide is on promotion at $149/mo against a regular $299, and compounded tirzepatide at a promotional $183/mo against a regular $399. It also carries NAD+ and several non-weight-loss generics. LegitScript certified.

Read our full NativeMed review →

Pros & Cons

Gala

What we like

  • Semaglutide costs $179 a month, close to the $185 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $149 a month, 40% below the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price stays the same as your dose goes up
  • The monthly price includes the medication, clinician visits and shipping
  • Serves all 50 states
  • We found no FDA warning letters issued to Gala

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

NativeMed

What we like

  • Semaglutide costs $149 a month, 19% below the $185 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $183 a month, 27% below the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication and shipping

Watch-outs

  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • The FDA has issued NativeMed a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Gala

Gala wins this one, 8.7 to 7.0, above all for moving between compounded and brand without changing seller. NativeMed fits better if compounded semaglutide at $149/month is your priority.

Choose Gala if…

You want moving between compounded and brand without changing seller and an opening price near $149 a month.

Choose NativeMed if…

You want compounded semaglutide at $149/month and an opening price near $149 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

6.1

DudeMeds

Compounded semaglutide at $175/month

7.8

Oak

Semaglutide at $119/month, 37% below the typical price

9.4

Trimi Health

Knowing which pharmacy fills the vial: it names VialsRx

Gala vs NativeMed: FAQ

Neither on the entry price: Gala and NativeMed both start at about $149 a month. The difference is in what the price includes.
Yes, both sell semaglutide and tirzepatide.
Gala lists 50 states; NativeMed does not publish where it ships. Confirm your state before paying.
Both include the medication itself and shipping. Only Gala includes the clinician visit.
Gala has none. NativeMed has an open FDA warning letter from June 8, 2026.
Gala pays us a commission on sign-ups through our links; NativeMed does not. Scores are computed the same way for both.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.